Skip to main content
Erschienen in: European Journal of Epidemiology 9/2014

01.09.2014 | GENETIC EPIDEMIOLOGY

Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants

verfasst von: Linda Broer, Julia Raschenberger, Joris Deelen, Massimo Mangino, Veryan Codd, Kirsi H. Pietiläinen, Eva Albrecht, Najaf Amin, Marian Beekman, Anton J. M. de Craen, Christian Gieger, Margot Haun, Peter Henneman, Christian Herder, Iiris Hovatta, Annika Laser, Lyudmyla Kedenko, Wolfgang Koenig, Barbara Kollerits, Eeva Moilanen, Ben A. Oostra, Bernhard Paulweber, Lydia Quaye, Aila Rissanen, Michael Roden, Ida Surakka, Ana M. Valdes, Katriina Vuolteenaho, Barbara Thorand, Ko Willems van Dijk, Jaakko Kaprio, Tim D. Spector, P. Eline Slagboom, Nilesh J. Samani, Florian Kronenberg, Cornelia M. van Duijn, Karl-Heinz Ladwig

Erschienen in: European Journal of Epidemiology | Ausgabe 9/2014

Einloggen, um Zugang zu erhalten

Abstract

Oxidative stress and inflammation are major contributors to accelerated age-related relative telomere length (RTL) shortening. Both conditions are strongly linked to leptin and adiponectin, the most prominent adipocyte-derived protein hormones. As high leptin levels and low levels of adiponectin have been implicated in inflammation, one expects adiponectin to be positively associated with RTL while leptin should be negatively associated. Within the ENGAGE consortium, we investigated the association of RTL with adiponectin and leptin in seven independent cohorts with a total of 11,448 participants. We performed partial correlation analysis on Z-transformed RTL and LN-transformed leptin/adiponectin, adjusting for age and sex. In extended models we adjusted for body mass index (BMI) and C-reactive protein (CRP). Adiponectin showed a borderline significant association with RTL. This appeared to be determined by a single study and when the outlier study was removed, this association disappeared. The association between RTL and leptin was highly significant (r = −0.05; p = 1.81 × 10−7). Additional adjustment for BMI or CRP did not change the results. Sex-stratified analysis revealed no difference between men and women. Our study suggests that high leptin levels are associated with short RTL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772–83.PubMedCrossRef Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol. 2006;6(10):772–83.PubMedCrossRef
2.
Zurück zum Zitat Conde J, et al. At the crossroad between immunity and metabolism: focus on leptin. Expert Rev Clin Immunol. 2010;6(5):801–8.PubMedCrossRef Conde J, et al. At the crossroad between immunity and metabolism: focus on leptin. Expert Rev Clin Immunol. 2010;6(5):801–8.PubMedCrossRef
4.
Zurück zum Zitat Enriori PJ, et al. Leptin resistance and obesity. Obesity (Silver Spring). 2006;14(Suppl 5):254S–8S.CrossRef Enriori PJ, et al. Leptin resistance and obesity. Obesity (Silver Spring). 2006;14(Suppl 5):254S–8S.CrossRef
5.
Zurück zum Zitat Blackburn EH, Gall JG. A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol. 1978;120(1):33–53.PubMedCrossRef Blackburn EH, Gall JG. A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol. 1978;120(1):33–53.PubMedCrossRef
6.
Zurück zum Zitat Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, tetrahymena and yeast to human cancer and aging. Nat Med. 2006;12(10):1133–8.PubMedCrossRef Blackburn EH, Greider CW, Szostak JW. Telomeres and telomerase: the path from maize, tetrahymena and yeast to human cancer and aging. Nat Med. 2006;12(10):1133–8.PubMedCrossRef
7.
Zurück zum Zitat Halvorsen TL, et al. Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol. 2000;166(1):103–9.PubMedCrossRef Halvorsen TL, et al. Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol. 2000;166(1):103–9.PubMedCrossRef
8.
Zurück zum Zitat Kurz DJ, et al. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci. 2004;117(Pt 11):2417–26.PubMedCrossRef Kurz DJ, et al. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. J Cell Sci. 2004;117(Pt 11):2417–26.PubMedCrossRef
9.
Zurück zum Zitat von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27(7):339–44.CrossRef von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem Sci. 2002;27(7):339–44.CrossRef
10.
Zurück zum Zitat von Zglinicki T, et al. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res. 1995;220(1):186–93.CrossRef von Zglinicki T, et al. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res. 1995;220(1):186–93.CrossRef
11.
Zurück zum Zitat Brouilette S, et al. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol. 2003;23(5):842–6.PubMedCrossRef Brouilette S, et al. White cell telomere length and risk of premature myocardial infarction. Arterioscler Thromb Vasc Biol. 2003;23(5):842–6.PubMedCrossRef
12.
Zurück zum Zitat Brouilette SW, et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet. 2007;369(9556):107–14.PubMedCrossRef Brouilette SW, et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet. 2007;369(9556):107–14.PubMedCrossRef
13.
Zurück zum Zitat Fitzpatrick AL, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 2007;165(1):14–21.PubMedCrossRef Fitzpatrick AL, et al. Leukocyte telomere length and cardiovascular disease in the cardiovascular health study. Am J Epidemiol. 2007;165(1):14–21.PubMedCrossRef
14.
Zurück zum Zitat Kalantar-Zadeh K, et al. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol. 2006;26(2):118–33.PubMedCrossRef Kalantar-Zadeh K, et al. Epidemiology of dialysis patients and heart failure patients. Semin Nephrol. 2006;26(2):118–33.PubMedCrossRef
15.
Zurück zum Zitat Aviv A, et al. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinol Metab. 2006;91(2):635–40.PubMedCrossRef Aviv A, et al. Menopause modifies the association of leukocyte telomere length with insulin resistance and inflammation. J Clin Endocrinol Metab. 2006;91(2):635–40.PubMedCrossRef
16.
Zurück zum Zitat Diaz VA, et al. Telomere length and adiposity in a racially diverse sample. Int J Obes (Lond). 2010;34(2):261–5.CrossRef Diaz VA, et al. Telomere length and adiposity in a racially diverse sample. Int J Obes (Lond). 2010;34(2):261–5.CrossRef
17.
Zurück zum Zitat Njajou OT, et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond). 2011;36:1176.CrossRef Njajou OT, et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond). 2011;36:1176.CrossRef
18.
Zurück zum Zitat Njajou OT, et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond). 2012;36(9):1176–9.CrossRef Njajou OT, et al. Shorter telomeres are associated with obesity and weight gain in the elderly. Int J Obes (Lond). 2012;36(9):1176–9.CrossRef
19.
Zurück zum Zitat Valdes AM, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366(9486):662–4.PubMedCrossRef Valdes AM, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005;366(9486):662–4.PubMedCrossRef
20.
Zurück zum Zitat Zhu H, et al. Leukocyte telomere length in healthy Caucasian and African-American adolescents: relationships with race, sex, adiposity, adipokines, and physical activity. J Pediatr. 2011;158(2):215–20.PubMedCrossRefPubMedCentral Zhu H, et al. Leukocyte telomere length in healthy Caucasian and African-American adolescents: relationships with race, sex, adiposity, adipokines, and physical activity. J Pediatr. 2011;158(2):215–20.PubMedCrossRefPubMedCentral
21.
Zurück zum Zitat Al-Attas OS, et al. Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. Eur J Endocrinol. 2010;163(4):601–7.PubMedCrossRefPubMedCentral Al-Attas OS, et al. Adiposity and insulin resistance correlate with telomere length in middle-aged Arabs: the influence of circulating adiponectin. Eur J Endocrinol. 2010;163(4):601–7.PubMedCrossRefPubMedCentral
22.
Zurück zum Zitat Aulchenko YS, et al. Linkage disequilibrium in young genetically isolated Dutch population. Eur J Hum Genet. 2004;12(7):527–34.PubMedCrossRef Aulchenko YS, et al. Linkage disequilibrium in young genetically isolated Dutch population. Eur J Hum Genet. 2004;12(7):527–34.PubMedCrossRef
23.
Zurück zum Zitat Pardo LM, et al. The effect of genetic drift in a young genetically isolated population. Ann Hum Genet. 2005;69(Pt 3):288–95.PubMedCrossRef Pardo LM, et al. The effect of genetic drift in a young genetically isolated population. Ann Hum Genet. 2005;69(Pt 3):288–95.PubMedCrossRef
24.
Zurück zum Zitat Wichmann HE, et al. KORA-gen–resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen. 2005;67(Suppl 1):S26–30.PubMedCrossRef Wichmann HE, et al. KORA-gen–resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen. 2005;67(Suppl 1):S26–30.PubMedCrossRef
25.
Zurück zum Zitat Schoenmaker M, et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet. 2006;14(1):79–84.PubMed Schoenmaker M, et al. Evidence of genetic enrichment for exceptional survival using a family approach: the Leiden Longevity Study. Eur J Hum Genet. 2006;14(1):79–84.PubMed
26.
Zurück zum Zitat Beekman M, et al. Chromosome 4q25, microsomal transfer protein gene, and human longevity: novel data and a meta-analysis of association studies. J Gerontol A Biol Sci Med Sci. 2006;61(4):355–62.PubMedCrossRef Beekman M, et al. Chromosome 4q25, microsomal transfer protein gene, and human longevity: novel data and a meta-analysis of association studies. J Gerontol A Biol Sci Med Sci. 2006;61(4):355–62.PubMedCrossRef
27.
Zurück zum Zitat Moayyeri A et al. Cohort profile: TwinsUK and healthy ageing twin study. Int J Epidemiol. 2012. Moayyeri A et al. Cohort profile: TwinsUK and healthy ageing twin study. Int J Epidemiol. 2012.
28.
Zurück zum Zitat Heid IM, et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes. 2006;55(2):375–84.PubMedCrossRef Heid IM, et al. Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels and parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes. 2006;55(2):375–84.PubMedCrossRef
30.
Zurück zum Zitat Pietilainen KH, et al. Growth patterns in young adult monozygotic twin pairs discordant and concordant for obesity. Twin Res. 2004;7(5):421–9.PubMedCrossRef Pietilainen KH, et al. Growth patterns in young adult monozygotic twin pairs discordant and concordant for obesity. Twin Res. 2004;7(5):421–9.PubMedCrossRef
32.
Zurück zum Zitat R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R foundation for Statistical Computing; 2010. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R foundation for Statistical Computing; 2010.
33.
Zurück zum Zitat Knudson JD, et al. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep. 2008;10(6):434–9.PubMedCrossRef Knudson JD, et al. Leptin and mechanisms of endothelial dysfunction and cardiovascular disease. Curr Hypertens Rep. 2008;10(6):434–9.PubMedCrossRef
34.
Zurück zum Zitat Okamoto Y, et al. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond). 2006;110(3):267–78.CrossRef Okamoto Y, et al. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond). 2006;110(3):267–78.CrossRef
35.
Zurück zum Zitat Considine RV, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334(5):292–5.PubMedCrossRef Considine RV, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334(5):292–5.PubMedCrossRef
36.
Zurück zum Zitat Kistorp C, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112(12):1756–62.PubMedCrossRef Kistorp C, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005;112(12):1756–62.PubMedCrossRef
37.
38.
Zurück zum Zitat Maiolino G, et al. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab. 2008;93(9):3333–40.PubMedCrossRef Maiolino G, et al. Plasma adiponectin for prediction of cardiovascular events and mortality in high-risk patients. J Clin Endocrinol Metab. 2008;93(9):3333–40.PubMedCrossRef
39.
Zurück zum Zitat Menon V, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(9):2599–606.PubMedCrossRef Menon V, et al. Adiponectin and mortality in patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(9):2599–606.PubMedCrossRef
40.
Zurück zum Zitat Pilz S, et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab. 2006;91(11):4277–86.PubMedCrossRef Pilz S, et al. Adiponectin and mortality in patients undergoing coronary angiography. J Clin Endocrinol Metab. 2006;91(11):4277–86.PubMedCrossRef
41.
Zurück zum Zitat Jorsal A, et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int. 2008;74(5):649–54.PubMedCrossRef Jorsal A, et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. Kidney Int. 2008;74(5):649–54.PubMedCrossRef
42.
Zurück zum Zitat Kollerits B, et al. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int. 2007;71(12):1279–86.PubMedCrossRef Kollerits B, et al. Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int. 2007;71(12):1279–86.PubMedCrossRef
43.
Zurück zum Zitat Saraheimo M, et al. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care. 2008;31(6):1165–9.PubMedCrossRef Saraheimo M, et al. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Diabetes Care. 2008;31(6):1165–9.PubMedCrossRef
44.
Zurück zum Zitat van Himbergen TM, et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the framingham heart study. Arch Neurol. 2012;69:594.PubMedCrossRef van Himbergen TM, et al. Biomarkers for insulin resistance and inflammation and the risk for all-cause dementia and alzheimer disease: results from the framingham heart study. Arch Neurol. 2012;69:594.PubMedCrossRef
45.
Zurück zum Zitat Li S, et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–88.PubMedCrossRef Li S, et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302(2):179–88.PubMedCrossRef
46.
Zurück zum Zitat Costacou T, et al. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh epidemiology of diabetes complications study. Diabetologia. 2005;48(1):41–8.PubMedCrossRef Costacou T, et al. The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh epidemiology of diabetes complications study. Diabetologia. 2005;48(1):41–8.PubMedCrossRef
47.
Zurück zum Zitat Pischon T, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291(14):1730–7.PubMedCrossRef Pischon T, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291(14):1730–7.PubMedCrossRef
48.
Zurück zum Zitat Schulze MB, et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005;54(2):534–9.PubMedCrossRef Schulze MB, et al. Adiponectin and future coronary heart disease events among men with type 2 diabetes. Diabetes. 2005;54(2):534–9.PubMedCrossRef
49.
Zurück zum Zitat Arita Y, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79–83.PubMedCrossRef Arita Y, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79–83.PubMedCrossRef
50.
Zurück zum Zitat Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271(18):10697–703.PubMedCrossRef Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996;271(18):10697–703.PubMedCrossRef
51.
Zurück zum Zitat Maeda N, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8(7):731–7.PubMedCrossRef Maeda N, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med. 2002;8(7):731–7.PubMedCrossRef
52.
Zurück zum Zitat Han SH, et al. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis. 2009;52(2):126–40.PubMedCrossRef Han SH, et al. Antiatherosclerotic and anti-insulin resistance effects of adiponectin: basic and clinical studies. Prog Cardiovasc Dis. 2009;52(2):126–40.PubMedCrossRef
53.
Zurück zum Zitat Furuhashi M, et al. Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetes. Diabetes Care. 2004;27(9):2217–21.PubMedCrossRef Furuhashi M, et al. Possible impairment of transcardiac utilization of adiponectin in patients with type 2 diabetes. Diabetes Care. 2004;27(9):2217–21.PubMedCrossRef
54.
Zurück zum Zitat Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439–51.PubMedCrossRef Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005;26(3):439–51.PubMedCrossRef
55.
Zurück zum Zitat Nordfjall K, et al. Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring). 2008;16(12):2682–9.CrossRef Nordfjall K, et al. Telomere length is associated with obesity parameters but with a gender difference. Obesity (Silver Spring). 2008;16(12):2682–9.CrossRef
56.
Zurück zum Zitat Horn T, Robertson BC, Gemmell NJ. The use of telomere length in ecology and evolutionary biology. Heredity (Edinb). 2010;105(6):497–506.CrossRef Horn T, Robertson BC, Gemmell NJ. The use of telomere length in ecology and evolutionary biology. Heredity (Edinb). 2010;105(6):497–506.CrossRef
57.
Zurück zum Zitat Tsao TS, et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem. 2003;278(50):50810–7.PubMedCrossRef Tsao TS, et al. Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathways. J Biol Chem. 2003;278(50):50810–7.PubMedCrossRef
58.
Zurück zum Zitat Waki H, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003;278(41):40352–63.PubMedCrossRef Waki H, et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem. 2003;278(41):40352–63.PubMedCrossRef
59.
Zurück zum Zitat Wang Y, et al. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics. 2004;4(12):3933–42.PubMedCrossRef Wang Y, et al. Proteomic and functional characterization of endogenous adiponectin purified from fetal bovine serum. Proteomics. 2004;4(12):3933–42.PubMedCrossRef
60.
Zurück zum Zitat Hara K, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006;29(6):1357–62.PubMedCrossRef Hara K, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006;29(6):1357–62.PubMedCrossRef
61.
Zurück zum Zitat Komura N, et al. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J. 2008;72(1):23–8.PubMedCrossRef Komura N, et al. Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J. 2008;72(1):23–8.PubMedCrossRef
62.
63.
Zurück zum Zitat Newbold RR. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens). 2010;9(3):206–17.CrossRef Newbold RR. Impact of environmental endocrine disrupting chemicals on the development of obesity. Hormones (Athens). 2010;9(3):206–17.CrossRef
Metadaten
Titel
Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants
verfasst von
Linda Broer
Julia Raschenberger
Joris Deelen
Massimo Mangino
Veryan Codd
Kirsi H. Pietiläinen
Eva Albrecht
Najaf Amin
Marian Beekman
Anton J. M. de Craen
Christian Gieger
Margot Haun
Peter Henneman
Christian Herder
Iiris Hovatta
Annika Laser
Lyudmyla Kedenko
Wolfgang Koenig
Barbara Kollerits
Eeva Moilanen
Ben A. Oostra
Bernhard Paulweber
Lydia Quaye
Aila Rissanen
Michael Roden
Ida Surakka
Ana M. Valdes
Katriina Vuolteenaho
Barbara Thorand
Ko Willems van Dijk
Jaakko Kaprio
Tim D. Spector
P. Eline Slagboom
Nilesh J. Samani
Florian Kronenberg
Cornelia M. van Duijn
Karl-Heinz Ladwig
Publikationsdatum
01.09.2014
Verlag
Springer Netherlands
Erschienen in
European Journal of Epidemiology / Ausgabe 9/2014
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-014-9940-1

Weitere Artikel der Ausgabe 9/2014

European Journal of Epidemiology 9/2014 Zur Ausgabe